Discover the Latest Advancements in Clinical Immunology: Altrubio to Showcase at FOCIS 2023 Annual Meeting
AltruBio to Present at the Federation of Clinical Immunology Societies (FOCIS) 2023 Annual Meeting San Francisco, June 15, 2023 (GLOBE NEWSWIRE) AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company dedicated to the development of novel therapeutics for the treatment of immunological diseases with high unmet medical needs, today announced that the company…